Pharmaceutical Excipients Market Projected to Reach $15.99 Billion by 2031
The pharmaceutical excipients market is forecast to grow from $11.95 billion in 2026 to $15.99 billion by 2031, at a compound annual growth rate of 10.2%. Growth is driven by demand for generic drugs and novel formulations.
The global pharmaceutical excipients market is projected to reach USD 15.99 billion by 2031, an increase from USD 11.95 billion in 2026. The market is expected to grow at a compound annual growth rate (CAGR) of 10.2% during the forecast period. Key drivers for this growth include the rising demand for generic drugs, increased research and development investments, and the adoption of new technologies in drug formulation.
The Asia Pacific region is identified as the fastest-growing market segment, with an anticipated CAGR of 6.7%. Organic chemicals are expected to maintain the largest market share by product type. Topical formulations are also projected to exhibit the highest CAGR among formulation types.
Regulatory shifts, such as the FDA's Novel Excipient Review Pilot Program, are accelerating innovation in the sector. The rise of biologics and mRNA therapies has boosted demand for lipid nanoparticles and advanced stabilizers. Furthermore, 3D printing technologies are facilitating the development of excipients for personalized medicine.
Organic chemicals constitute the largest segment by product, playing a crucial role in ensuring the safety and efficacy of pharmaceutical formulations. The lubricants and glidants segment is also expected to experience significant growth, contributing to improved manufacturing efficiency, particularly for solid dosage forms.